809 related articles for article (PubMed ID: 29372812)
1. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
Maurice NM; Bedi B; Sadikot RT
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812
[TBL] [Abstract][Full Text] [Related]
2. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
3. Effect of ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat model.
Li F; Wang W; Hu L; Li L; Yu J
Chemotherapy; 2011; 57(2):173-80. PubMed ID: 21454975
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
[TBL] [Abstract][Full Text] [Related]
5. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.
Gellatly SL; Hancock RE
Pathog Dis; 2013 Apr; 67(3):159-73. PubMed ID: 23620179
[TBL] [Abstract][Full Text] [Related]
7. Shifting paradigms in Pseudomonas aeruginosa biofilm research.
Tart AH; Wozniak DJ
Curr Top Microbiol Immunol; 2008; 322():193-206. PubMed ID: 18453277
[TBL] [Abstract][Full Text] [Related]
8. Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.
Rodrigues ME; Lopes SP; Pereira CR; Azevedo NF; Lourenço A; Henriques M; Pereira MO
PLoS One; 2017; 12(1):e0170433. PubMed ID: 28114348
[TBL] [Abstract][Full Text] [Related]
9. Immune Responses to
Moser C; Jensen PØ; Thomsen K; Kolpen M; Rybtke M; Lauland AS; Trøstrup H; Tolker-Nielsen T
Front Immunol; 2021; 12():625597. PubMed ID: 33692800
[No Abstract] [Full Text] [Related]
10. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Esoda CN; Kuehn MJ
mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
[No Abstract] [Full Text] [Related]
11. BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa.
Li Y; Petrova OE; Su S; Lau GW; Panmanee W; Na R; Hassett DJ; Davies DG; Sauer K
PLoS Pathog; 2014 Jun; 10(6):e1004168. PubMed ID: 24901523
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.
Tetz G; Vikina D; Tetz V
Ann Clin Microbiol Antimicrob; 2016 Mar; 15():19. PubMed ID: 27001074
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa: acute lung injury or ventilator-associated pneumonia?
Berra L; Sampson J; Wiener-Kronish J
Minerva Anestesiol; 2010 Oct; 76(10):824-32. PubMed ID: 20935618
[TBL] [Abstract][Full Text] [Related]
15. The role of bacterial biofilms in chronic infections.
Bjarnsholt T
APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
Tolker-Nielsen T
APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
[TBL] [Abstract][Full Text] [Related]
17. The problems of antibiotic resistance in cystic fibrosis and solutions.
López-Causapé C; Rojo-Molinero E; Macià MD; Oliver A
Expert Rev Respir Med; 2015 Feb; 9(1):73-88. PubMed ID: 25541089
[TBL] [Abstract][Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
20. Rapid genetic and phenotypic changes in Pseudomonas aeruginosa clinical strains during ventilator-associated pneumonia.
Persyn E; Sassi M; Aubry M; Broly M; Delanou S; Asehnoune K; Caroff N; Crémet L
Sci Rep; 2019 Mar; 9(1):4720. PubMed ID: 30886315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
